Valent BioSciences

This new plant will complement the existing headquarters for its subsidiary company, Mycorrhizal Applications, in Grants Pass, OR.

VectoBac 200G, VectoBac 1200L, and VectoLex CG are larvicides used in the control of black flies and mosquitoes.

Salman Mir, currently Executive Vice President and Chief Operating Officer, has been named President and CEO, also effective July 2023.

Acquisition strengthens Valent BioSciences’ participation in the rapidly growing $3.5 billion global biostimulant market.

The new biostimulant business team is focused on discovering, developing, and commercializing arbuscular mycorrhizal fungi (AMF) products.

LEAP ES delivers two-way protection from both bacterial diseases and lepidopteran larvae that can reduce crop quality and yield.

Accede is the first PGR based on a naturally occurring compound developed specifically for thinning of stone fruit.